About Overview

Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally.

Our core strength and competitive advantage lies in our established presence in all major therapeutic areas including gynecology, cardiology, blood- related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets &they are the domestic leader in four biologics. We are leading creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trials.

200+

brands

5

R&D Centers

14

manufacturing facilities

70+

Countries

With 200+ brands, five R&D centers and 14 manufacturing facilities established across the country, we have ensured a strong foothold not just in India but also globally with a wide network of bases across 70+ countries. Our state-of-the-art API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.